This drug reduces mortality risk by 62% among COVID patients. Read on for details
New York: New data revealed by Gilead Sciences has shown that its antiviral drug remdesivir reduces death risk of severe ...
Read moreNew York: New data revealed by Gilead Sciences has shown that its antiviral drug remdesivir reduces death risk of severe ...
Read moreNew Delhi: Pharma major Cipla said Wednesday it has launched its generic version of anti-viral drug remdesivir at a price ...
Read moreBhubaneswar: The Odisha government received Monday the first consignment of ‘Remdesivir’ and ‘Favipiravir’ medicines for treatment of COVID-19 patients. Additional ...
Read moreNew Delhi: Anti-viral drug ‘remdesivir’ and ‘tocilizumab’, an immunomodulator, are being considered for ‘restricted use’ on severely ill COVID-19 patients ...
Read moreNew York: Remdesivir, the antiviral under clinical trials for treatment against novel coronavirus infection, is superior to the standard of ...
Read moreGuru Prasad Mohanta A cure for COVID-19 is most important. Japan, among others, is the latest to approve Remdesivir for ...
Read moreNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read moreMumbai: Indian equity markets posted decent recoveries Thursday as sentiment improved on promising early results from a COVID-19 drug trial. ...
Read moreWashington: A top United States infectious disease official has said Gilead Sciences Inc’s experimental antiviral drug ‘remdesivir’ is giving success. ...
Read moreLondon: The coronavirus-ravaged world was hoping that some sort of vaccine will soon emerge to fight the deadly disease. There ...
Read more